Dr. Matthew Hicks, naturopathic doctor, Oregon-licensed psilocybin facilitator, and lead investigator on the first clinical trial conducted inside a state-regulated psychedelic program, joins Sam Chapman to discuss what he found. The conversation covers his group treatment model that cut costs by more than half, the unexpected outcomes his team measured, and why this research could move Medicaid coverage of psilocybin therapy from a hopeful idea to a fundable program.

Retired police lieutenant and Law Enforcement Action Partnership (LEAP) Executive Director Diane Goldstein joins Sam Chapman to discuss drug policy reform, the role of psychedelics in addressing law enforcement trauma, and LEAP's advocacy for psychedelic access and mental health support. The conversation also covers the fiscal case for legal psychedelic access and the broader psychological and societal costs of current drug policy.

To launch Ground Game, Sam Chapman speaks with Dr. Adie Rae, co-director of the Open Psychedelic Evaluation Nexus, the team at the center of a historic $3.3 million NIDA grant to track outcomes in Oregon's legal psilocybin program. The conversation covers what Oregon's program has already revealed about safety and efficacy, what this federal investment signals for the future of psychedelic access nationwide, and much more.